5-dimethylamino-1-(4-(2-methylbenzoylamino)benzoyl)-2,3,4,5-tetrahydro-1H-benzazepine,
benzamide, N-(4-((5-(dimethylamino)-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl)carbonyl)phenyl)-2-methyl-, hydrochloride (1:1),
mozavaptan,
mozavaptan hydrochloride,
mozavaptane hydrochloride,
N-(4-(((5RS)-5-(dimethylamino)-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl)carbonyl)phenyl)-2-methylbenzamide,
OPC 31260,
OPC-31260,
physuline,
Mozavaptan hydrochloride,
138470-70-9,
Physuline,
OPC 31260 hydrochloride,
C27H30ClN3O2,
mozavaptan HCl,
5-(Dimethylamino)-1-[4-(2-methylbenzamido)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine hydrochloride,
Mozavaptane hydrochloride,
AC1LCS5E,
SCHEMBL1111095,
Mozavaptane hydrochloride (JAN),
CHEBI:31869,
CTK8F0008,
BCP25023,
MFCD11111965,
AKOS015969260,
ACN-048914,
SB18800,
AC-23018,
RT-013946,
FT-0689853,
X6952,
OPC 31260 hydrochloride, >=98% (HPLC),
D01855,
J-007136,
Benzamide, N-[4-[[5-(dimethylamino)-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]carbonyl]phenyl]-2-methyl-, hydrochloride (1:1),
N-[4-(5-Dimethylamino-2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl)phenyl]-2-methylbenzamide hydrochloride,
N-[4-[5-(dimethylamino)-2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl]phenyl]-2-methylbenzamide hydrochloride,
MozavaptanHydrochloride,
UNII-F39AR1YW1O,
F39AR1YW1O,
Opc-31260,
Opc 31260,
CID636389,